Impressive boosting of anti-S1/S2 IgG production in COVID-19-experienced patients after the first shot of the BNT162b2 mRNA COVID-19 Vaccine

類似資料

• Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study
  著者:: Borgonovo, Fabio, 等
  出版事項: (2021)
• One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG
  著者:: Capetti, Amedeo F., 等
  出版事項: (2021)
• BNT162b2 vaccine for prevention of COVID-19
  出版事項: (2021)
• Short‐term inhibition of SARS‐CoV‐2 by hydrogen peroxide in persistent nasopharyngeal carriers
  著者:: Capetti, Amedeo F., 等
  出版事項: (2020)
• Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine.
  著者:: Pezzati, Laura, 等
  出版事項: (2021)